Pharmafile Logo
Pharmafocus logo
Advanced Search

Lutathera

Showing 3 posts of 3 posts found.

novartis_outside_1

Dutch health minister attacks Novartis over orphan drug price hike

January 15, 2019
Manufacturing and Production Cancer, Lutathera, NL, Netherlands, Novartis, oncology

Dutch health minister Bruno Bairns has called for a meeting with Swiss multinational Novartis after the multibillion-dollar firm introduced a …

News
novartissunlight_copy

Radioactive drug given approval by the FDA

January 29, 2018
Sales and Marketing Advanced Accelerator Applications, Lutathera, Novartis, biotech, drugs, pharma, pharmaceutical

The FDA has approved Lutathera, marking the first time that the agency has given approval for a radioactive drug or …

News
novartis_window

Novartis to bolster oncology portfolio with $3.9 billion acquisition

October 30, 2017
Sales and Marketing Advanced Acclerator Applications, Lutathera, Novartis, pharma

Novartis has announced its intention to acquire France’s Advanced Accelerator Applications (AAA) for $3.9 billion in a move to reinforce …

News
The Gateway to Local Adoption Series

Latest content

Femtosecond laser cuts lung tumour margin assessment time

October 15, 2026

Blood sensor detects Parkinson’s-associated proteins in 40 minutes

October 15, 2026

Cori Clinical raises US$4m to expand AI platform for clinical trial design

October 14, 2026

Ofichem acquires US drug substance CDMO Kinentia

October 14, 2026

Jager-van Dijk is new Arletta Pharma Solutions CEO 

October 13, 2026